Featured Articles

Findings from an international genomics consortium almost double the number of associated genetic loci and variants for AMD

Research conducted by the International AMD Genomics Consortium (IAMDGC) has recently reported an almost doubling in the number of genetic risk loci associated with age-related macular degeneration (AMD). In a significant publication in the journal Nature Genetics, the research group has reported on an analysis of >12 million gene variants, “including 163,714 directly genotyped, mostly […]

Read full story

Allergan (NYSE:AGN) and CRISPR company, Editas Medicine Inc. (NASDAQ:EDIT), announce strategic deal to focus on eye diseases

Allergan Inc. (NASDAQ:AGN) and Editas Medicine Inc. (NASDAQ:EDIT) have announced the execution of an exclusive licensing transaction in which Allergan receives an option on up to five of Editas’ CRISPR ocular research programmes, including Editas’ lead programme for a product candidate to treat Lebers congenital amaurosis (LCA10). Under the terms of the deal Editas will […]

Read full story

Three patients are reported to have suffered significant vision loss following “stem cell” treatment in a Florida clinic

A brief report, published in the New England Journal of Medicine (NEJM 2017;376:1047-53), has highlighted three cases of severe vision loss in elderly female patients following autologous “stem cell” treatment. The report, from the Bascom Palmer Eye Institute, University of Miami, Florida, follows the management of three cases of vision loss in patients with age-related […]

Read full story

Related Featured News